Vurdering af reguleringsmæssige behov - liste
Vurdering af reguleringsmæssige behov - liste
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 23 april 2024. Database contains 4860 unique substances/entries.
292-562-0
|
90640-43-0
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-apr.-2019
|
Details | |
This substance is identified by SDA Substance Name: N-C12-C18 alkyl propylene diamine and SDA Reporting Number: 16-032-00.
|
268-957-9
|
68155-37-3
|
Sweden
|
Carcinogenic Mutagenic Respiratory sensitiser Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
16-apr.-2019
|
Details |
696-364-9
|
133779-11-0
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-apr.-2019
|
Details | |
629-719-3
|
1219010-04-4
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-apr.-2019
|
Details | |
show/hide
|
799-976-5
|
-
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
SVHC
|
29-apr.-2019
|
Details |
215-607-8
|
1333-82-0
|
Netherlands
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
None
|
15-maj-2019
|
Details | |
203-404-7
|
106-50-3
|
Netherlands
|
Other environmental toxicity Other human toxicity |
Concluded
|
CLH Restriction |
15-maj-2019
|
Details | |
233-660-5
|
10294-40-3
|
Netherlands
|
Carcinogenic |
Concluded
|
CLH
|
28-maj-2019
|
Details | |
276-090-2
|
71850-09-4
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
28-maj-2019
|
Details | |
939-597-6
|
-
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
1 - 2.5 moles ethoxylated
|
500-343-0
|
157627-92-4
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-344-6
|
157627-94-6
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-513-4
|
161074-79-9
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
932-185-7
|
1187742-72-8
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
939-578-2
|
-
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
939-575-6
|
-
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
1 - 2.5 moles ethoxylated
|
500-234-8
|
68891-38-3
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-189-4
|
68081-91-4
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-345-1
|
157627-95-7
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-233-2
|
68891-29-2
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
939-523-2
|
-
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
1 - 2.5 moles ethoxylated
|
500-464-9
|
160901-27-9
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
1 - 2.5 moles ethoxylated
|
500-465-4
|
160901-28-0
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | |
221-416-0
|
3088-31-1
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
266-840-7
|
67656-24-0
|
ECHA
|
Under development
|
CCH
|
07-jun.-2019
|
Details | ||
201-289-8
|
80-54-6
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
25-jun.-2019
|
Details | |
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
Austria
|
Toxic for reproduction |
Concluded
|
SVHC
|
08-jul.-2019
|
Details |
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
Austria
|
Toxic for reproduction |
Concluded
|
SVHC
|
08-jul.-2019
|
Details |
204-112-2
|
115-86-6
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
Other
|
10-sep.-2019
|
Details | |
812-927-5
|
1902936-62-2
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | ||
426-650-9
|
191743-75-6
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | ||
TINUVIN 123
|
406-750-9
|
129757-67-1
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | |
482-440-7
|
-
|
ECHA
|
Under development
|
No action
|
30-sep.-2019
|
Details | ||
687-535-9
|
122586-52-1
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | ||
433-060-5
|
290822-07-0
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | ||
700-878-1
|
1395069-30-3
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | ||
CGL 116
|
425-020-0
|
191680-81-6
|
ECHA
|
Under development
|
CCH
|
30-sep.-2019
|
Details | |
-
|
-
|
France
|
Carcinogenic Mutagenic Other human toxicity Toxic for reproduction |
Concluded
|
Restriction
|
12-nov.-2019
|
Details | |
287-477-0
|
85535-85-9
|
United Kingdom
|
Bioaccumulation Persistence Toxic for reproduction |
Concluded
|
SVHC Restriction |
03-dec.-2019
|
Details | |
259-048-8
|
54261-67-5
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
10-dec.-2019
|
Details | |
234-277-6
|
11059-65-7
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
10-dec.-2019
|
Details | |
214-012-0
|
1072-63-5
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
16-dec.-2019
|
Details | |
211-765-7
|
693-98-1
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
16-dec.-2019
|
Details | |
245-152-0
|
22673-19-4
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
07-jan.-2020
|
Details | |
214-946-9
|
1222-05-5
|
France
|
Endocrine disruption |
Concluded
|
Other
|
22-jan.-2020
|
Details | |
246-669-4
|
25152-85-6
|
ECHA
|
Concluded
|
CCH CLH |
28-jan.-2020
|
Details | ||
226-685-8
|
5451-76-3
|
ECHA
|
Concluded
|
No action
|
28-jan.-2020
|
Details | ||
226-641-8
|
5444-75-7
|
ECHA
|
Concluded
|
CCH CLH |
28-jan.-2020
|
Details | ||
611-930-7
|
60045-26-3
|
ECHA
|
Concluded
|
CCH CLH |
28-jan.-2020
|
Details | ||
200-618-2
|
65-85-0
|
ECHA
|
Concluded
|
No action
|
28-jan.-2020
|
Details | ||